We are live on ! Find out more
PCM

Peregrine Capital Management Portfolio holdings

AUM $3.08B
1-Year Est. Return 29.51%
This Fund
S&P 500
This Quarter Est. Return
+5.79%
1 Year Est. Return
+29.51%
3 Year Est. Return
+95.04%
5 Year Est. Return
+107.83%
10 Year Est. Return
+715.34%
AUM
$4.05B
AUM Growth
+$54.3M
Cap. Flow
-$70M
Cap. Flow %
-1.73%
Top 10 Hldgs %
10.14%
Holding
326
New
22
Increased
54
Reduced
163
Closed
21

Sector Composition

Rank Sector Weight
1 Technology 21.3%
2 Healthcare 18.83%
3 Financials 14.97%
4 Industrials 14.07%
5 Consumer Discretionary 12.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PANW icon
101
Palo Alto Networks
PANW
$297B
$17M 0.42%
499,656
TRHC
102
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$16.8M 0.41%
335,984
+57,639
+21% +$2.87M
ALNY icon
103
Alnylam Pharmaceuticals
ALNY
$29.3B
$16.8M 0.41%
231,042
+37,821
+20% +$2.9M
KNX icon
104
Knight Transportation
KNX
$11.4B
$16.8M 0.41%
510,163
-769
-0.2% -$24.5K
NVTA
105
DELISTED
Invitae Corporation
NVTA
$16.5M 0.41%
702,358
+61,488
+10% +$1.31M
CIR
106
DELISTED
CIRCOR International, Inc
CIR
$16.4M 0.4%
355,676
-163,461
-31% -$6.33M
MGPI icon
107
MGP Ingredients
MGPI
$375M
$16.2M 0.4%
244,632
+52,059
+27% +$3.67M
EAF icon
108
GrafTech
EAF
$212M
$16.2M 0.4%
140,787
-319
-0.2% -$37.4K
IOVA icon
109
Iovance Biotherapeutics
IOVA
$2.87B
$16.1M 0.4%
657,651
-173,864
-21% -$2.62M
SIMO icon
110
Silicon Motion
SIMO
$8.68B
$16.1M 0.4%
363,263
-1,459
-0.4% -$58.6K
CDNA icon
111
CareDx
CDNA
$2.42B
$15.9M 0.39%
442,172
-49,524
-10% -$1.59M
IT icon
112
Gartner
IT
$11.7B
$15.8M 0.39%
97,958
+13,692
+16% +$2.14M
WNC icon
113
Wabash National
WNC
$527M
$15.7M 0.39%
967,238
-2,875
-0.3% -$42.3K
EBS icon
114
Emergent Biosolutions
EBS
$248M
$15.6M 0.39%
323,885
+25,799
+9% +$1.24M
ONTO icon
115
Onto Innovation
ONTO
$15.3B
$15.6M 0.39%
450,328
+141,135
+46% +$4.51M
MDRX
116
DELISTED
Veradigm Inc. Common Stock
MDRX
$15.6M 0.38%
1,340,532
-2,654
-0.2% -$27K
HUBG icon
117
HUB Group
HUBG
$2.92B
$15.5M 0.38%
736,768
-1,932
-0.3% -$40.6K
TYL icon
118
Tyler Technologies
TYL
$12.8B
$15.4M 0.38%
71,490
+10,031
+16% +$2.18M
STLD icon
119
Steel Dynamics
STLD
$37.6B
$15.2M 0.38%
502,965
-968
-0.2% -$29.6K
PGTI
120
DELISTED
PGT, Inc.
PGTI
$15.2M 0.37%
907,463
-2,572
-0.3% -$39.2K
BKNG icon
121
Booking.com
BKNG
$161B
$14.7M 0.36%
195,750
VIRT icon
122
Virtu Financial
VIRT
$4.93B
$14.6M 0.36%
668,900
+2,153
+0.3% +$50.6K
AIR icon
123
AAR Corp
AIR
$5.76B
$14.4M 0.36%
392,703
-864
-0.2% -$28.6K
ZUO
124
DELISTED
Zuora, Inc.
ZUO
$14.4M 0.36%
940,167
-1,939
-0.2% -$36.7K
ACAD icon
125
Acadia Pharmaceuticals
ACAD
$5.03B
$14.4M 0.36%
538,278
-1,166
-0.2% -$29.8K

Similar funds

Peregrine Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Peregrine Capital Management held 326 positions worth $4.05B, up 1.4% from $4B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Peregrine Capital Management's Q2 2019 filing shows 22 new, 54 increased, 163 reduced and 21 closed positions. Its largest new stake was Black Knight, Inc. Common Stock: 361,870 shares worth $21.8M. The largest sale was Cadence Design Systems, an estimated $26.6M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Peregrine Capital Management's largest Q2 2019 buy was Black Knight, Inc. Common Stock: 361,870 shares worth $21.8M.
  • Peregrine Capital Management added most to HealthEquity in Q2 2019, an estimated $18.3M increase.
  • Peregrine Capital Management's biggest Q2 2019 reduction was Medidata Solutions, Inc., cutting an estimated $26.3M.
  • Peregrine Capital Management fully exited Cadence Design Systems in Q2 2019, selling an estimated $26.6M.
  • Peregrine Capital Management's ten largest holdings make up 10% of its $4.05B portfolio in Q2 2019.
  • Peregrine Capital Management opened 22 new positions and closed 21 in Q2 2019.
  • Peregrine Capital Management's portfolio value rose 1.4% quarter-over-quarter to $4.05B.

Based on Peregrine Capital Management's 13F filing for Q2 2019, filed 18 Jul 2019.